Electrophysiology Ablation Market Segmentations by product type - ablation catheter, diagnostic catheter and access devices; by application - Supraventricular Tachycardia (SVT) ablation, Ventricular Tachycardia (VT/VPC) and Atrial Fibrillation (AF)

Creating Monetary Value through Innovation

The electrophysiology ablation market has observed substantial progress over the past few years. Ongoing research will create the landscape for further product innovation in the electrophysiological ablation market. Market leaders are focusing on sustaining premium segment leadership in the electrophysiology ablation market. As the general electrophysiology ablation market is consolidated in terms of electrophysiology ablation catheters, market leaders are focusing on expanding their product portfolios to strengthen their customer insight capabilities on a global level.

Electrophysiology Ablation is Now Considered to Be the First Line of Treatment for Arrhythmias

Electrophysiology ablation has grown into an effective treatment option for indicative, drug-resistant atrial fibrillation (AF), and has lately been implemented as a first line of treatment for patients with paroxysmal atrial fibrillation. The usage pattern for antiarrhythmic drugs, which witnessed a shift due to the emergence of clear-cut electrophysiology ablation procedures, has made a huge impact on sales, which, in turn, has been affecting the overall revenue generated from the antiarrhythmic drug market. Electrophysiology ablation is expected to gain popularity, as it provides great benefits for the patient, with reduced side-effects and optimum results.

Close to 90% Revenue Contribution by Leading Manufacturers in the Market

The electrophysiology ablation market is largely consolidated and dominated by the global manufactures of such products. The consolidated nature of the market and the accessibility of reasonable products decrease the profitability of the business in the concerned market. However, the growing awareness about electrophysiology ablation and the growing demand for cost-effective diagnostic options have increased revenue opportunities for global manufacturers. Companies such as Biosense Webster, Abbott Laboratories, MEDTRONIC PLC, and Boston Scientific Corporation, which together account for close to 90% revenue of the electrophysiology ablation market. These companies have dominated the market for a long time now. Their main priority is the launch of novel product lines for the market. Further, companies operating in the electrophysiology ablation market are collaborating with local distributors/retailers to increase the penetration of their products.

Multiple Uses of Conventional Catheters

Most catheters used in electrophysiology ablation are for single use. The market for electrophysiology ablation is considered to be ruled by the big four companies present in cardiac care. However, with new companies emerging in the industry, products that can revolutionize the product scope can be expected. CathRx launched the first ‘reposable’ diagnostic and therapeutic catheter for the treatment of cardiac arrhythmias, which is a niche product in the electrophysiology ablation market.

Increase in the Worldwide Prevalence and Incidence Rate of AF with Significant Effects

Atrial fibrillation (AF) is a type of arrhythmic condition where the heart function gets disrupted by abnormal beating through electrical signals in no particular order. The AF condition can be for a shorter duration as well as for a longer time, and both require effective treatment, which is ablation in most cases. The significant rise in the number of cases of AF makes it the most prominent application segment for the procedure of electrophysiology ablation. AF treatments account for a substantial percentage of the NHS budget in the U.K. The U.S. market also shows a high number of reported AF cases, with projections showing a rise in the coming years. AF is not the only factor having some effect over the market. Conditions that are associated with AF also push the market, as early treatment is suggested. The electrophysiology ablation market is highly driven by this macro trend.

Competitive Landscape

The report on the electrophysiology ablation market details information on the growth parameters of electrophysiology ablation companies. The study encompasses comprehensive data on each stakeholder, including Biosense Webster, Abbott Laboratories, MEDTRONIC PLC, CathRx Ltd, Biotronik SE & Co. KG., Japan Lifeline Co., Boston Scientific Corporation, Auris Health, ATRICURE, INC., and Biomerics. Details in the electrophysiology ablation market report include market revenue shares of product manufacturers, and latest information on key strategies in the concerned market, apart from many other fundamental dynamics.

About the Report

The electrophysiology ablation market study provides comprehensive information about the most important market dynamics that prove instrumental in the growth of the EP market during 2018-2026. Market players can find the most accurate dynamics, including both, quantitative and qualitative information about the growth parameters of other electrophysiology ablation catheter and access device manufacturers, which is expected to aid the development of data-driven business strategies over the forecast period.

Segmentation

The electrophysiology ablation market is segmented as per geography, product type, application, and end user, to analyze the segment-wise revenue growth of the electrophysiology ablation market. Based on geography, the market is segmented into seven regions – North America, Europe, CIS & Russia, Latin America, Asia Pacific Excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA). The electrophysiology ablation market is segmented into product type - ablation catheters, diagnostic catheters, and access devices. By application, the electrophysiology ablation market is segmented as supraventricular tachycardia (SVT) ablation, ventricular tachycardia (VT/VPC), and atrial fibrillation (AF). By end user, the electrophysiology ablation market is segmented into hospitals, ambulatory surgical centers, and clinics.

Additional Questions Answered

Readers would find detailed information about the important positive and negative factors affecting the electrophysiology ablation market during the forecast period. Besides, the market report also contains invaluable information that can provide electrophysiology ablation manufacturers with answers to critical questions, such as:

• Which EP product type accounts for the maximum demand in the concerned market? Why is it so?
• Why are the sales of EP products the highest in developed markets?
• Which factors are influencing the competitive strategies of players in the market?
• What strategies are being applied by EP product manufacturers in order to sustain themselves in the competitive market?

Research Methodology

The process of market research followed at the company commences with extensive secondary research of the electrophysiology ablation market. Analysts obtain industry-validated, historic, and current data about the demand for electrophysiology ablation across the globe. Comprehensive secondary research is followed by extensive and in-depth primary research, where detailed information about the electrophysiology ablation market is obtained in terms of value (US$ Million). Based on thorough secondary and primary research of the growth parameters of the electrophysiology ablation market, analysts come up with the most precise forecast on how the electrophysiology ablation market will grow during the forecast period.